Following
the global actions to phase out perfluoroctanesulfonic
acid (PFOS) a large number of alternative per- and polyfluoroalkyl
substances, with poorly defined hazard properties, are being used
in increasing quantities. Here, we report on the first detection of
the chlorinated polyfluoroalkyl ether sulfonic acid F-53B in biological
samples and determine the tissue distribution and whole body bioaccumulation
factors (BAFwhole body) in crucian carp (Carassius
carassius). Analysis of fish samples from Xiaoqing River
(XR) and Tangxun Lake (TL) demonstrated a similar level of F-53B contamination
with median concentrations in blood of 41.9 and 20.9 ng/g, respectively.
Tissue/blood ratios showed that distribution of F-53B primarily occurs
to the kidney (TL: 0.48, XR: 0.54), gonad (TL: 0.36, XR: 0.54), liver
(TL: 0.38, XR: 0.53), and heart (TL: 0.47, XR: 0.47). Median Log BAFwhole body values for F-53B (XR: 4.124, TL: 4.322) exceeded
regulatory bioaccumulation criterion and were significantly higher
than those of PFOS in the same data sets (XR: 3.430, TL: 3.279). On
the basis of its apparent omnipresence and strong bioaccumulation
propensity, it is hypothesized that F-53B could explain a significant
fraction of previously unidentified organofluorine in biological samples
from China, and regulatory actions for this compound are encouraged.